- 242 Downloads
The ichthyoses are a heterogeneous group of disorders with both inherited and acquired forms. Clinical presentation, pattern of inheritance, and laboratory evaluation may establish a precise diagnosis, which can assist in prognosis and genetic counseling.
Congenital autosomal recessive ichthyosis (CARI) usually presents at birth, often as a collodion baby. CARI can progress into any one of a spectrum of disorders. Lamellar ichthyosis is characterized by dark, plate (armor)-like scale. This disease is often caused by mutations in the gene encoding the enzyme transglutaminase 1. Congenital ichthyosiform erythroderma is another phenotype within CARI, marked by generalized redness and fine white scale.
Epidermolytic hyperkeratosis is an autosomal dominant disorder characterized by hyperkeratosis and blistering, and at least six clinical phenotypes have been described. It may be due to mutations in the gene encoding the intermediate filament proteins keratin 1 and 10.
Ichthyosis vulgaris is the most common ichthyosis, and is inherited in an autosomal dominant pattern. Involvement is generally mild and may vary greatly with climate and humidity. X-linked ichthyosis, due to a defect in the enzyme steroid sulfatase, affects males with generalized scaling that usually begins soon after birth. There may be associated corneal opacities that do not affect vision.
Sjögren-Larsson syndrome is an autosomal recessive ichthyosis associated with progressive spastic paralysis and mental retardation. This condition is caused by mutations in the gene for fatty aldehyde dehydrogenase. Refsum’s disease, due to accumulation of phytanic acid, results in ichthyosis and progressive neurologic dysfunction.
The erythrokeratodermas are characterized by hyperkeratosis and localized erythema. Erythrokeratodermia variabilis is autosomal dominant and characterized by generalized or localized hyperkeratosis and migratory red patches. Mutations in the genes encoding the gap junction proteins, connexins, underlie this disorder.
Netherton’s syndrome is an autosomal recessive disorder characterized by ichthyosis, a hair shaft abnormality and atopy. The ichthyosis may present at birth with erythroderma or in some cases a collodion presentation. However, a frequent characteristic skin manifestation is ichthyosis linearis circumflexa. Netherton’s syndrome has been found to be due to an abnormality in a serum protease inhibitor. Acquired ichthyosis can have a variety of underlying causes including neoplastic, infectious, drugs, endocrine, metabolic, autoimmune, malabsorptive states, and hereditary. Topical, and in more severe cases, systemic, therapy are useful in managing this array of disorders of cornification.
KeywordsPhytanic Acid Liarozole Calcipotriol Ointment TGM1 Lamellar Ichthyosis
Dr DiGiovanna has received travel and speaking honoraria and clinical research support from Hoffman-LaRoche, and clinical research support from Allergan, who market retinoid drugs.
- 3.DiGiovanna JJ. Ichthyosiform dermatoses. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 581–603Google Scholar
- 31.Griffiths WAD, Judge MR, Leigh IM. Disorders of keratinization. In: Champion RH, Burton JL, Burns DA, et al., editors. Rook/Wilkinson/Ebling textbook of dermatology. Oxford: Blackwell Science, 1998: 1483–1530Google Scholar
- 32.Sneddon IB. Acquired ichthyosis in Hodgkin’s disease. Br J Dermatol 1955; 1: 763–764Google Scholar
- 66.Parsons Jr WB. Treatment of hypercholesteremia by nicotinic acid: progress report with review of studies regarding mechanism of action. Arch Intern Med (Chicago) 1961; 107: 639–652Google Scholar
- 76.GeneTests GeneClinics. Laboratory directory [online]. Available from URL: www.genetests.org [Accessed 2002 Dec 6]Google Scholar
- 79.Robinson-Bostom L, McDonald CJ. Ichthyosis. In: McDonald CJ, editor. Immunomodulatory and cytotoxic agents in dermatology. New York: Marcel Deckker, 1997: 293–300Google Scholar
- 94.Peck GL, DiGiovanna JJ. The retinoids. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 2810–2820Google Scholar
- 97.Soriatane package insert. Nutley (NJ): Roche Laboratories Inc., 2001 JanGoogle Scholar
- 98.Isotretinoin package insert. Nutley (NJ): Roche Laboratories Inc., 2002 JunGoogle Scholar